{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:30:49Z","timestamp":1790652649064,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.atherosclerosis.2016.01.026","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T08:12:35Z","timestamp":1453191155000},"page":"325-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Myeloid interferon-\u03b3 receptor deficiency does not affect atherosclerosis in LDLR-\/- mice"],"prefix":"10.1016","volume":"246","author":[{"given":"Marieke C.S.","family":"Boshuizen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette E.","family":"Neele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion J.J.","family":"Gijbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5981-121X","authenticated-orcid":false,"given":"Marten A.","family":"Hoeksema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Van den Bossche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno P.J.","family":"de Winther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.atherosclerosis.2016.01.026_bib1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2016.01.026_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.01.026_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J.\u00a0Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.01.026_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s11883-012-0240-5","article-title":"Molecular pathways regulating macrophage polarization: implications for atherosclerosis","volume":"14","author":"Hoeksema","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.01.026_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frostegard","year":"1999","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.01.026_bib6","first-page":"169","article-title":"Detection of activated T lymphocytes in the human atherosclerotic plaque","volume":"135","author":"Hansson","year":"1989","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2016.01.026_bib7","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/ATVBAHA.115.305464","article-title":"Interferons as essential modulators of atherosclerosis","volume":"35","author":"Boshuizen","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2016.01.026_bib8","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-gamma potentiates atherosclerosis in ApoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J.\u00a0Clin. Invest"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.01.026_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1291\/hypres.30.259","article-title":"Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice","volume":"30","author":"Koga","year":"2007","journal-title":"Hypertens. Res."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2016.01.026_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/CIRCRESAHA.106.147256","article-title":"Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice","volume":"101","author":"Koga","year":"2007","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.01.026_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5551\/jat.11.79","article-title":"Interferon-gamma produced by bone marrow-derived cells attenuates atherosclerotic lesion formation in LDLR-deficient mice","volume":"11","author":"Niwa","year":"2004","journal-title":"J.\u00a0Atheroscler. Thromb."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.01.026_bib12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/10799900260100141","article-title":"IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-\/- mice","volume":"22","author":"Whitman","year":"2002","journal-title":"J.\u00a0Interferon Cytokine Res."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2016.01.026_bib13","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0002-9440(10)64820-1","article-title":"Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-\/- mice","volume":"157","author":"Whitman","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"36","key":"10.1016\/j.atherosclerosis.2016.01.026_bib14","doi-asserted-by":"crossref","first-page":"20915","DOI":"10.1074\/jbc.270.36.20915","article-title":"Interaction between the components of the interferon gamma receptor complex","volume":"270","author":"Kotenko","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.01.026_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1359-6101(97)00009-9","article-title":"The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor","volume":"8","author":"Pestka","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.01.026_bib16","doi-asserted-by":"crossref","first-page":"e1004635","DOI":"10.1371\/journal.ppat.1004635","article-title":"IFNgamma signaling endows DCs with the capacity to control type I inflammation during parasitic infection through promoting T-bet+ regulatory T cells","volume":"11","author":"Lee","year":"2015","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2016.01.026_bib17","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200318580","article-title":"Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice","volume":"112","author":"Kanters","year":"2003","journal-title":"J.\u00a0Clin. Invest"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.01.026_bib18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1172\/JCI110980","article-title":"Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes","volume":"72","author":"Guyre","year":"1983","journal-title":"J.\u00a0Clin. Invest"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2016.01.026_bib19","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1186\/gb-2007-8-9-r200","article-title":"Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis","volume":"8","author":"Kleemann","year":"2007","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.01.026_bib20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","article-title":"Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis","volume":"48","author":"Wouters","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.01.026_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.ATV.0000059419.11002.6E","article-title":"Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse","volume":"23","author":"Buono","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.026_bib22","doi-asserted-by":"crossref","first-page":"393946","DOI":"10.1155\/2010\/393946","article-title":"The expression and functions of toll-like receptors in atherosclerosis","volume":"2010","author":"Cole","year":"2010","journal-title":"Mediat. Inflamm."},{"issue":"6696","key":"10.1016\/j.atherosclerosis.2016.01.026_bib23","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/29788","article-title":"Decreased lesion formation in CCR2-\/- mice reveals a role for chemokines in the initiation of atherosclerosis","volume":"394","author":"Boring","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.01.026_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1097-2765(00)80139-2","article-title":"Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice","volume":"2","author":"Gu","year":"1998","journal-title":"Mol. cell"},{"key":"10.1016\/j.atherosclerosis.2016.01.026_bib25","doi-asserted-by":"crossref","first-page":"936109","DOI":"10.4061\/2011\/936109","article-title":"Atherosclerotic plaque stability is affected by the chemokine CXCL10 in both mice and humans","volume":"2011","author":"Segers","year":"2011","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.atherosclerosis.2016.01.026_bib26","doi-asserted-by":"crossref","first-page":"893106","DOI":"10.1155\/2014\/893106","article-title":"The multifaceted functions of CXCL10 in cardiovascular disease","volume":"2014","author":"van den Borne","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2016.01.026_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molcel.2014.08.020","article-title":"Extracellular vesicles from neural stem cells transfer IFN-gamma via Ifngr1 to activate Stat1 signaling in target cells","volume":"56","author":"Cossetti","year":"2014","journal-title":"Mol. cell"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.01.026_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.immuni.2006.08.014","article-title":"Complex modulation of cell type-specific signaling in response to type I interferons","volume":"25","author":"van Boxel-Dezaire","year":"2006","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2016.01.026_bib29","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1084\/jem.185.7.1231","article-title":"Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice","volume":"185","author":"Taylor","year":"1997","journal-title":"J.\u00a0Exp. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2016.01.026_bib30","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.4049\/jimmunol.160.3.1359","article-title":"Factors involved in regulating primary and secondary immunity to infection with histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma","volume":"160","author":"Zhou","year":"1998","journal-title":"J.\u00a0Immunol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2016.01.026_bib31","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","article-title":"Local proliferation dominates lesional macrophage accumulation in atherosclerosis","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2016.01.026_bib32","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1084\/jem.20090866","article-title":"GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions","volume":"206","author":"Zhu","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.026_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1476-511X-10-211","article-title":"Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging","volume":"10","author":"Meyrelles","year":"2011","journal-title":"Lipids health Dis."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2016.01.026_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2011.01.001","article-title":"Regulation of hepatocyte fate by interferon-gamma","volume":"22","author":"Horras","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2016.01.026_bib35","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1172\/JCI70405","article-title":"JUNB\/AP-1 controls IFN-gamma during inflammatory liver disease","volume":"123","author":"Thomsen","year":"2013","journal-title":"J.\u00a0Clin. Invest"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016300260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016300260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T14:45:28Z","timestamp":1692197128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016300260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":35,"alternative-id":["S0021915016300260"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.026","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid interferon-\u03b3 receptor deficiency does not affect atherosclerosis in LDLR-\/- mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}